Cape Investment Advisory, Inc. Bristol Myers Squibb CO Transaction History
Cape Investment Advisory, Inc.
- $102 Billion
- Q3 2025
A detailed history of Cape Investment Advisory, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cape Investment Advisory, Inc. holds 326 shares of BMY stock, worth $15,260. This represents 0.01% of its overall portfolio holdings.
Number of Shares
326
Previous 410
20.49%
Holding current value
$15,260
Previous $19 Million
22.56%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding BMY
# of Institutions
2,680Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...